Biodexa Pharmaceticals Stock Buy Hold or Sell Recommendation

BDRX Stock   1.90  0.09  4.52%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Biodexa Pharmaceticals is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Biodexa Pharmaceticals given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Biodexa Pharmaceticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Biodexa Pharmaceticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Biodexa Stock please use our How to Invest in Biodexa Pharmaceticals guide.
In addition, we conduct extensive research on individual companies such as Biodexa and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Biodexa Pharmaceticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Biodexa Pharmaceticals Buy or Sell Advice

The Biodexa recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biodexa Pharmaceticals. Macroaxis does not own or have any residual interests in Biodexa Pharmaceticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biodexa Pharmaceticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Biodexa PharmaceticalsBuy Biodexa Pharmaceticals
Cautious Hold

Market Performance

Very WeakDetails

Volatility

RiskyDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very HighDetails

Economic Sensitivity

Actively responds to the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Biodexa Pharmaceticals has a Mean Deviation of 4.3, Standard Deviation of 6.83 and Variance of 46.62
We provide trade advice to complement the prevailing expert consensus on Biodexa Pharmaceticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Biodexa Pharmaceticals is not overpriced, please confirm all Biodexa Pharmaceticals fundamentals, including its gross profit, as well as the relationship between the short ratio and total asset . Please also double-check Biodexa Pharmaceticals shares owned by institutions to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Biodexa Pharmaceticals Trading Alerts and Improvement Suggestions

Biodexa Pharmaceticals generated a negative expected return over the last 90 days
Biodexa Pharmaceticals has high historical volatility and very poor performance
Biodexa Pharmaceticals may become a speculative penny stock
Biodexa Pharmaceticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 381 K. Net Loss for the year was (7.08 M) with profit before overhead, payroll, taxes, and interest of 145 K.
Biodexa Pharmaceticals generates negative cash flow from operations
Biodexa Pharmaceticals has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP

Biodexa Pharmaceticals Returns Distribution Density

The distribution of Biodexa Pharmaceticals' historical returns is an attempt to chart the uncertainty of Biodexa Pharmaceticals' future price movements. The chart of the probability distribution of Biodexa Pharmaceticals daily returns describes the distribution of returns around its average expected value. We use Biodexa Pharmaceticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biodexa Pharmaceticals returns is essential to provide solid investment advice for Biodexa Pharmaceticals.
Mean Return
-1.19
Value At Risk
-11.63
Potential Upside
9.56
Standard Deviation
6.83
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biodexa Pharmaceticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Biodexa Pharmaceticals Cash Flow Accounts

202020212022202320242025 (projected)
Change In Cash(3.4M)2.5M(7.2M)3.1M2.8M3.0M
Free Cash Flow(9.5M)(6.3M)(7.1M)(7.1M)(6.4M)(6.7M)
Depreciation1.2M403K343K283K254.7K242.0K
Other Non Cash Items430K(892K)454K397K357.3K603.6K
Capital Expenditures209K320K62K263K236.7K380.6K
Net Income(22.2M)(5.5M)(7.7M)(7.1M)(6.4M)(6.7M)
End Period Cash Flow7.5M10.1M2.8M6.0M5.4M8.0M
Investments2.6M(278K)(220K)(265K)(304.8K)(320.0K)

Biodexa Pharmaceticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biodexa Pharmaceticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biodexa Pharmaceticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biodexa stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-1.03
β
Beta against Dow Jones1.63
σ
Overall volatility
7.07
Ir
Information ratio -0.16

Biodexa Pharmaceticals Volatility Alert

Biodexa Pharmaceticals is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biodexa Pharmaceticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biodexa Pharmaceticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Biodexa Pharmaceticals Fundamentals Vs Peers

Comparing Biodexa Pharmaceticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biodexa Pharmaceticals' direct or indirect competition across all of the common fundamentals between Biodexa Pharmaceticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biodexa Pharmaceticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biodexa Pharmaceticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Biodexa Pharmaceticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Biodexa Pharmaceticals to competition
FundamentalsBiodexa PharmaceticalsPeer Average
Return On Equity-0.97-0.31
Return On Asset-0.38-0.14
Operating Margin(79.31) %(5.51) %
Current Valuation(4.73 M)16.62 B
Shares Outstanding668.59 K571.82 M
Shares Owned By Insiders8.82 %10.09 %
Shares Owned By Institutions29.85 %39.21 %
Number Of Shares Shorted46.95 K4.71 M
Price To Book0.12 X9.51 X
Price To Sales15.31 X11.42 X
Revenue381 K9.43 B
Gross Profit145 K27.38 B
EBITDA(7.16 M)3.9 B
Net Income(7.08 M)570.98 M
Total Debt464 K5.32 B
Book Value Per Share24.07 X1.93 K
Cash Flow From Operations(6.83 M)971.22 M
Short Ratio0.03 X4.00 X
Earnings Per Share(77.66) X3.12 X
Target Price18.6
Number Of Employees2118.84 K
Beta1.5-0.15
Market Capitalization1.27 M19.03 B
Total Asset10.54 M29.47 B
Retained Earnings(144.77 M)9.33 B
Working Capital1.46 M1.48 B
Net Asset10.54 M

Biodexa Pharmaceticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biodexa . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Biodexa Pharmaceticals Buy or Sell Advice

When is the right time to buy or sell Biodexa Pharmaceticals? Buying financial instruments such as Biodexa Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Biodexa Pharmaceticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Hedge Favorites Thematic Idea Now

Hedge Favorites
Hedge Favorites Theme
Hedge Funds pool capital from accredited individuals or institutional investors and invest in a variety of assets, often with complex portfolio-construction and risk-management techniques. The Hedge Favorites theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hedge Favorites Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Biodexa Stock Analysis

When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.